在接种疫苗的医疗保健工作者中,COVID-19后肺功能评估
Lorenzo Ippoliti1, Luca Coppeta2, Giuseppina Somma2
1Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, 00133, Italy. ippoliti.lo@libero.it.
Journal of occupational medicine and toxicology (London, England)
|December 15, 2023
概括
虽然COVID-19感染对医护人员的肺功能产生了负面影响,但疫苗接种显著地保护了这些呼吸系统的下降,特别是强迫生命能力 (FVC). 这凸显了疫苗接种对高压工人的重要性.
科学领域:
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
- 疫苗学 疫苗学 疫苗学
背景情况:
- COVID-19可能会导致持续的症状,如疲劳和胸痛,肺部损伤是严重结果的关键因素.
- COVID-19对呼吸功能的长期影响,特别是在轻度病例中,仍然不确定.
- 疫苗对严重的COVID-19是有效的,但它对轻度感染的呼吸功能的影响需要进一步调查.
研究的目的:
- 分析2020-2022年期间COVID-19感染后的医疗保健工作者 (HCW) 肺功能变化.
- 为了比较HCWs的前和后流行性螺旋测试结果.
- 评估疫苗接种状态对SARS-CoV-2感染后呼吸功能的影响.
主要方法:
- 对321台高温电机的螺旋计数据进行了回顾性分析.
- 在COVID-19感染之前和之后的肺功能参数 (FVC,FEV1,FEV1/FVC,PEF) 的比较.
- 线性回归分析,以评估疫苗对呼吸系统参数的保护作用.
主要成果:
- 在流行后,除了FEV1/FVC比率外,螺旋计参数的显著下降也被观察到.
- 与非感染者相比,受感染者在2020年和2021年显著减少了强迫生命能力 (FVC).
- 感染前的疫苗接种与FVC的显着较低的下降有关.
结论:
- 2020-2021年亚临床SARS-CoV-2感染对呼吸系统参数 (FVC,FEV1) 有不利影响.
- 接种COVID-19疫苗证明了对这些呼吸系统下降的保护作用,特别是对于FVC.
- 疫苗接种卫生保健工作者对于减轻COVID-19的长期呼吸系统后果至关重要.
相关概念视频
Pulmonary Function Tests
335
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
335
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Pneumonia III: Complications and Assessment
239
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
239
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
COPD: Management Using Bronchodilators and Corticosteroids
213
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
213
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


